Stock Region Penny Picks Newsletter - Thursday, January 16, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The following newsletter is intended to provide informational updates on stocks with recent developments and should not be interpreted as financial advice. Investors are encouraged to perform their own due diligence before making investment decisions.
Today’s Featured Watchlist
Seres Therapeutics ($MCRB)
Seres Therapeutics has received a $50 million installment payment tied to the VOWST sale, driving attention to the biotech company’s financial stability. Current price stands at $0.76.ZenaTech ($ZENA)
ZenaTech is advancing its heavy-lift gas-powered drone version of the ZenaDrone 1000, targeting the U.S. Defense and NATO markets. This development could position ZenaTech as a prominent player in military-grade drones.Palisade Bio ($PALI)
The biotech firm has completed all five SAD cohorts of its Phase 1a/b study for PALI-2108, a treatment for ulcerative colitis, and will now progress to MAD cohorts. This milestone highlights continued progress in their clinical pipeline.Biomerica ($BMRA)
Biomerica's Fortel® PSA screening test for early detection of prostate cancer has been approved by the United Arab Emirates Ministry of Health and Prevention. This approval expands the company's international footprint.Blaize ($BZAI)
Blaize, in collaboration with alwaysAI, aims to revolutionize AI edge computing and computer vision applications for real-time insights. The company was oversold earlier today at $7.48, suggesting potential for a rebound.Flexible Solutions International ($FSI)
FSI saw strong movements, trading over VWAP at $5.60 earlier today after announcing a new contract for food-grade manufacturing.FOXO Technologies ($FOXO)
FOXO has confirmed details of its special meeting of shareholders scheduled for January 17, 2025. This meeting is expected to address key decisions for the company’s future direction.iSpecimen Inc. ($ISPC)
iSpecimen has secured suppliers for the flu-like human metapneumovirus (hMPV). This strategic move could support the company’s expansion into this growing market.Versus Systems ($VS)
Versus Systems has announced its expansion into Brazil, one of the largest gaming markets worldwide. This move positions the company to capture significant international gaming revenue.
Disclaimer: This newsletter is for educational and informational purposes only. Stock investments carry risks, and past performance does not guarantee future results. Always consult a licensed financial advisor before making any investment decisions.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net
Happy Tracking,
Stock Region Editorial Team